Jackie07
06-23-2011, 04:52 PM
[From www.clinicaloptions.com (http://www.clinicaloptions.com/) ]<O:p</O:p
New Directions in the Treatment of Patients With HER2-Positive Breast Cancer<O:p</O:p
Source: New Directions in HER2-Positive Breast Cancer<O:p</O:p
By: Dennis J Slamon, MD, PhD, Sara Hurvitz, MD
<TABLE style="mso-cellspacing: 1.5pt; mso-yfti-tbllook: 1184" class=MsoNormalTable border=0 cellPadding=0><TBODY><TR style="mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes"><TD style="BORDER-BOTTOM: #f0f0f0; BORDER-LEFT: #f0f0f0; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #f0f0f0; BORDER-RIGHT: #f0f0f0; PADDING-TOP: 0.75pt" vAlign=top>Explore optimal treatment strategies for patients with HER2-positive breast cancer. Topics include:
Mechanism of action of HER2-targeted agents
Recommended regimens for first-line treatment
Treatment strategies for patients who progress after treatment with HER2-targeted therapy
Agents under investigation for HER2-positive metastatic breast cancer
To begin, please click on the icon at the right. Mac Users: Slides will download to your desktop. This slide presentation is in Microsoft PowerPoint format and is available for download within the CME module (Slides (http://www.clinicaloptions.com/Oncology/Treatment%20Updates/HER2-Positive%20Breast%20Cancer/Slideset%20Module/HER2_Positive_Breast_Cancer/Pages/Page%201/Slides.aspx?lg=FileDownload)).
When the presentation is complete, close the window and then complete the posttest and evaluation, accessible by clicking the “Test” tab above.
</TD></TR></TBODY></TABLE>
New Directions in the Treatment of Patients With HER2-Positive Breast Cancer<O:p</O:p
Source: New Directions in HER2-Positive Breast Cancer<O:p</O:p
By: Dennis J Slamon, MD, PhD, Sara Hurvitz, MD
<TABLE style="mso-cellspacing: 1.5pt; mso-yfti-tbllook: 1184" class=MsoNormalTable border=0 cellPadding=0><TBODY><TR style="mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes"><TD style="BORDER-BOTTOM: #f0f0f0; BORDER-LEFT: #f0f0f0; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #f0f0f0; BORDER-RIGHT: #f0f0f0; PADDING-TOP: 0.75pt" vAlign=top>Explore optimal treatment strategies for patients with HER2-positive breast cancer. Topics include:
Mechanism of action of HER2-targeted agents
Recommended regimens for first-line treatment
Treatment strategies for patients who progress after treatment with HER2-targeted therapy
Agents under investigation for HER2-positive metastatic breast cancer
To begin, please click on the icon at the right. Mac Users: Slides will download to your desktop. This slide presentation is in Microsoft PowerPoint format and is available for download within the CME module (Slides (http://www.clinicaloptions.com/Oncology/Treatment%20Updates/HER2-Positive%20Breast%20Cancer/Slideset%20Module/HER2_Positive_Breast_Cancer/Pages/Page%201/Slides.aspx?lg=FileDownload)).
When the presentation is complete, close the window and then complete the posttest and evaluation, accessible by clicking the “Test” tab above.
</TD></TR></TBODY></TABLE>